The Regulatory and Scientific Affairs team at SteroTherapeutics is responsible for navigating the regulatory landscape to ensure the compliance and approval of the company’s novel drug therapy for Non-alcoholic steatohepatitis. They collaborate closely with clinical advisors to design and implement research protocols, analyze scientific data, and communicate findings to regulatory bodies, ultimately aiming to facilitate efficient drug development and market entry.
View all